OPTIMUM×NOVO NORDISKOPTIMUM×NOVO NORDISKAt the invitation of Novo Nordisk, the Optimum Clinics team gathered to share its vision for weight, wellness and metabolic care in Oman.
At the invitation of Novo Nordisk, the Optimum Clinics team gathered at the Crowne Plaza for what proved to be an exceptional session, an afternoon hosted with genuine warmth and scientific depth by the Novo Nordisk team.
Much of the discussion centred on the science of semaglutide: its mechanism, its clinical evidence, and its role in modern weight and metabolic care. Mr. Dilip of Novo Nordisk delivered an outstanding presentation on the therapeutic detail, and Mr. Mohamed Elewa, Novo Nordisk's Country Manager in Oman, added context that was as constructive as it was clear.
The conversation reached well beyond the clinical. Optimum's Clinical Director, Mohammad Aref Bagherzadeh, briefly presented the clinic's CRM and patient-data approach, and both teams explored the infrastructure of partnership itself, including patient-journey systems and a shared approach to marketing. Guided throughout by Novo Nordisk's leadership in metabolic medicine, what began as a presentation became a genuine framework for working together.
The science of semaglutide, in service of better outcomes for Oman.
the heart of the Optimum × Novo Nordisk discussionDelivered an outstanding, in-depth presentation on the science of semaglutide: its mechanism, evidence, and clinical role.
Added expert context that made the session both highly constructive and clear, a generous and valued contribution.
An in-depth look at mechanism and clinical evidence, presented by Mr. Dilip of Novo Nordisk, with expert context from Mr. Mohamed Elewa.
Optimum's physician-led assessment, InBody composition analysis, and structured weight programmes.
A brief look at Optimum's CRM and patient-data systems, presented by Clinical Director Mohammad Aref Bagherzadeh.
With Novo Nordisk's guidance, a shared approach to marketing and a framework for raising the standard of care across Oman.
Optimum Clinics extends its sincere thanks to Novo Nordisk for a warm welcome and an outstanding session.
Our appreciation goes to Mr. Dilip for his excellent presentation on the science of semaglutide, and to Mr. Mohamed Elewa, Country Manager in Oman, whose insight and generosity made the afternoon so constructive. We look forward to the work ahead, together.
×
Together, redefining weight & wellness care.